Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.65B
Enterprise Value8.92B
P/E Ratio-144.75
PEG Ratio-0.21
Price/Sales Ratio6.87
Price/Book Ratio3.08
Enterprise/Revenue7.19
Enterprise/EBITDA-143.98

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.13
Operating Margin-0.1
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.06

Income Statement

Revenue1.12B
Revenue/Share1.89
Gross Profit1.14B
EBITDA-23.08M
Net Income-167.24M
Diluted EPS-0.32

Balance Sheet

Total Cash568.77M
Total Cash/Share0.93
Total Debt942.34M
Total Debt/Equity0.37
Current Ratio1.28
Book Value Per Share4.35

Price History

52-Week Change6.22
52-Week High36.24
52-Week Low8.53
Moving Average 50 Days10.08
Moving Average 200 Days16.26

Statistics

Average Volume14.29M
Shares Outstanding611.69M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.26
Last Split Factor8:5
Last Split DateJune 10, 2008
AD